KureCare updates regenerative wound treatment services ahead of January 2026 Medicare reimbursement changes. The program addresses chronic wounds through root-cause healing protocols, with nationwide access to certified clinics offering Medicare-covered biologics and comprehensive care coordination.
-- KureCare has announced service updates to its regenerative wound treatment program in response to Medicare policy changes taking effect January 1, 2026. The team emphasizes that patients establishing care before the deadline may be able to retain access to advanced treatment protocols under existing coverage guidelines, while post-deadline enrollment could face restricted options.
To learn more about chronic wound treatment options, go to https://curewounds.com
The service addresses a critical gap in traditional wound care, which typically treats surface symptoms without resolving underlying barriers to healing. Chronic wounds persist when systemic issues like compromised circulation, nutritional deficiencies, inflammation, or immune dysfunction prevent tissue repair. KureCare's approach targets these root causes through regenerative biologics combined with protocols to reduce inflammation and restore circulation.
Treatment begins with comprehensive diagnostic testing to identify specific healing obstacles in each patient. The team then deploys Medicare Part B-covered amniotic grafts and advanced biologics proven to accelerate wound closure rates. This regenerative methodology achieves complete healing in approximately 42 days across multiple wound types, including diabetic foot ulcers, pressure sores, venous leg ulcers, and persistent surgical wounds.
The nationwide network spans 300+ certified clinics across all 50 states, each trained in regenerative care delivery and Medicare compliance requirements. Patients receive coordinated support from initial assessment through complete wound closure, with the company handling authorization paperwork and insurance documentation. Qualified Medicare patients typically pay zero out-of-pocket costs for covered treatments.
"We've treated more than 47,000 chronic wounds by addressing what standard care misses," stated Founder Kenton Gray. "When you restore circulation, reduce inflammation, and support the body's natural repair systems, wounds that seemed hopeless begin healing within weeks. With Medicare coverage potentially changing, patients need to understand their window for accessing these treatments under current rules."
With KureCare's technology, 95% of patients achieve complete wound closure, with measurable improvement typically visible within the first 14 days of treatment. Enrollment includes free discovery calls for Medicare verification, provider matching within 24 hours, and treatment protocols customized to individual patient needs.
The service update comes as Medicare changes at the start of 2026 mean that some medical procedures under Traditional Medicare will need prior authorization in six U.S. states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington.
For service details, clinic locations, and Medicare coverage verification, visit https://curewounds.com
Contact Info:
Name: Kenton Gray
Email: Send Email
Organization: KureCare a division of Veracor Group LLC
Address: 1150 NW 72ND AVE TOWER 1 STE 455 #20073 , Miami, FL 33126, United States
Website: https://curewounds.com
Source: PressCable
Release ID: 89178488
Should any problems, inaccuracies, or doubts arise from the content contained within this press release, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is at the core of our commitment to our readers.
